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Prion propagationPrion diseases are associated to the conversion of the prion protein into a misfolded pathological isoform. The
mechanism of propagation of protein misfolding by protein templating remains largely unknown. Neuroblasto-
ma cells were transfected with constructs of the prion protein fused to both CFP-GPI-anchored and to YFP-GPI-
anchored and directed to its cell membrane location. Live-cell FRET imaging between the prion protein fused
to CFP or YFP was measured giving consistent values of 10 ± 2%. This result was conﬁrmed by ﬂuorescence
lifetime imaging microscopy and indicates intermolecular interactions between neighbor prion proteins. In par-
ticular, considering that a maximum FRET efﬁciency of 17 ± 2% was determined from a positive control
consisting of a fusion CFP-YFP-GPI-anchored. A stable cell clone expressing the two fusions containing the
prion protein was also selected to minimize cell-to-cell variability. In both, stable and transiently transfected
cells, the FRET efﬁciency consistently increased in the presence of infectious prions — from 4 ± 1% to 7 ± 1%
in the stable clone and from 10 ± 2% to 16 ± 1% in transiently transfected cells. These results clearly reﬂect an
increased clustering of the prion protein on the membrane in the presence of infectious prions, which was not
observed in negative control using constructs without the prion protein and upon addition of non-infected
brain. Our data corroborates the recent view that the primary site for prion conversion is the cell membrane.
Since our ﬂuorescent cell clone is not susceptible to propagate infectivity, we hypothesize that the initial event
of prion infectivity might be the clustering of the GPI-anchored prion protein.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Prions, a class of proteinaceous infectious self-reproducing agents
discovered by S. Prusiner, cause fatal neurodegenerative diseases due
to misfolding and aggregation of the prion protein. Also termed trans-
missible spongiform encephalophaties (TSEs), these diseases occur
when an abnormal isoform of the prion protein named PrPSc acts as a
transmissible agent being able to induce the conversion of endogenous
cellular prion protein (PrPC) into new PrPSc molecules which then form
aggregates. The infectious characteristic of prion diseases imposes
threat to public health as shown by the outbreak of mad cow disease
(BSE) in the 80s. The appearance of this novel disease in cattle, its source
of infection likely to be related to feed and especially its most probable
transmissibility to humans by consumption of BSE-contaminated beef
products [1] has stimulated investigation on prion diseases. Moreover,
the mechanism of propagation of protein misfolding by corruptive
protein templating thought to be exclusive of prion diseases has now
been proven to occur in other proteophaties such as Alzheimer,
Parkinson and Huntington diseases conferring renewed interest to the51 289818419.study of prion diseases [2–4]. Increasingly efforts to solve key aspects
of prion diseases have been undertaken but several questions still
require deﬁnite insight such as the cell biology of prion conversion
and the role of the prion protein in other neurodegenerative diseases,
namely as receptor for Aβ oligomers [5], or the proteolytic cleavage of
PrPC impact on prion diseases [6]. The infectivity mechanism of prion
diseases requires protein interaction between PrPSc and the host PrPC,
which is a glycoprotein anchored to the cell membrane through a
glycophosphatidylinositol (GPI) anchor. The nature of the PrPSc entity
is still under scrutiny and recent reports point to a dynamic collection
of two distinct populations of particles [7]. Enhancement of resistance
to proteolysis of PrPSc reduces its infectivity by decreasing frangibility
pointing to a key role of PrPSc oligomers on infectivity [8]. It seems
that rates of transmissibility and disease progression are governed by
the selection of progressively less stable, faster replicating PrPSc
conformers. The membrane location of PrPC and especially its GPI-
anchor seem to be key for prion conversion and pathogenesis [9–12].
One of the aspects that need deeper insight is certainly the characteriza-
tion of the initial event in prion conversion and infectivity: (i) How do
cells respond to extracellular prion aggregates? (ii) What is the initial
step and where is the primary site of prion conversion? Recently, it
was shown that prion infectivity is extremely rapid and the plasma
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(ﬂuorescence resonance energy transfer) has been increasingly used
to examine the membrane organization of GPI-anchored proteins
[14,15]. FRET measurements have the high sensitivity of ﬂuorescence
measurements and are sensitive to near-Angstrom biological relevant
distances thus being widely used to study biomolecular interactions
in cells [16]. The cyan and yellow ﬂuorescent protein (CFP and YFP,
respectively) pair has been commonly used to measure FRET in cells
due to their excitation and emission properties, suitable Förster distance
and easy photobleaching of YFP [17]. Using a novel cell system, express-
ing fusions between the prion protein and the CFP and YFP attached
to the cell membrane through a GPI anchor, we have carried out imag-
ing FRET measurements to characterize the interaction of infectious
prions with cells. Imaging FRET can be performed in several ways in-
cluding donor lifetimes [18], acceptor photobleaching [19], acceptor
photoactivation [20] and variations on sensitized acceptor ﬂuorescence
also called sensitized emission [21]. Acceptor photobleaching FRET on
ﬁxed cells was ﬁrst measured to characterize intermolecular FRET on
this novel cell system. Then, sensitized-emission FRET was chosen to
perform live-cell measurements, as the alternative based on acceptor
photobleaching causes phototoxicity and it is prone to errors resulting
from mobility of the donor and acceptor during scan time [22]. Using
live-cell sensitized emission FRET from CFP to YFP both fused to PrP,
this work shows that exogenous infectious prions promote clustering
of the prion protein attached to the cell membrane as the initial step
of interaction with cells.
2. Material and methods
2.1. DNA constructs
2.1.1. Site-directed mutagenesis of the mouse ORF of PrP to generate the
epitope to the mAb 3F4
The ORF of mouse PrP was mutagenized targeting the residues
L108M and V111M to generate the speciﬁc epitope for the mAb 3F4.
The L108M mutation was ﬁrst obtained with the primers 5′-cca aaa
acc atg aag cat gtg gca ggg-3′ (forward) and 5′-ccc tgc cac atg ctt cat
gtt ggt ttt tgg-3′ (reverse). The V111M mutation was then generated
using the template with the L108M mutation and the primers 5′-cca
aca tga agc ata tgg cag ggg ctg cgg-3′ (forward) and 5′-ccg cag ccc ctg
cca tat gct tca tgt tgg-3′ (reverse).
2.1.2. Generation of PrP-FP-GPI constructs targeted to the plasma
membrane
The sequences of YFP and CFP were ligated to the PrP sequence that
codes for the GPI-anchor preceded by 15 bp frommature PrP, to assure
that cleavage and GPI-anchor are processed correctly. This ligation was
performed ﬁrst by ampliﬁcation of the ﬂuorescence protein sequences
from the plasmids pEYFP and pECFP with the primers 5′-ggg aga aga
tcc agc atg gtg agc aag ggc-3′ (forward) and 5′-gga tct ccc gtc ctt gta
cag ctc gtc-3′ (reverse) and by ampliﬁcation of the sequence that
codes for the GPI-anchor with the primers 5′-gac gag ctg tac aag gac
ggg aga aga tcc-3′ (forward) and 5′-agt gga tcc tca tcc cac gat cag gaa-
3′ (reverse). SOEing of the two previous PCR products was carried out
using the primers 5′-gac gag ctg tac aag gac ggg aga aga tcc-3′ (forward)
and 5′-gga tct tct ccc gtc ctt gta cag ctc gtc-3′ (reverse) [23]. The
sequence that codes for FP-GPI was then ampliﬁed with the primers
5′-ttt tga att cat ggt gag caa ggg cga gga g-3′ (forward) and 5′-agt gga
tcc tca tcc cac gat cag gaa-3′ (reverse). The forward and reverse primers
have recognition sites for EcoRI and BamHI restriction enzymes, respec-
tively. The ORF of PrP with L108M and V111Mmutationswas ampliﬁed
to generate a GPI-anchorless sequence with recognition sites for the re-
striction enzymes HindIII and EcoRI using the primers 5′-ctt agg ctt atg
gcg aac ctt ggc tac-3′ (forward) and 5′-gcc ctt gct cac cat gct gga tct tct
ccc-3′ (reverse). The sequences YFP-GPI and CFP-GPI generated by
SOEing and the PrP-anchorless sequence were digested with EcoRIand ligated with T4 ligase (Promega, USA). The resulting PrP-YFP-GPI
and PrP-CFP-GPI sequences were then digested with HindIII and
BamHI and cloned into pcDNA 5.0/Hyg and pcDNA 3.1/Zeo plasmids
(Invitrogen, USA), respectively. Restriction enzymes were acquired
both from Promega (USA) and Nzytech (Portugal).
2.1.3. Generation of FP-GPI constructs targeted to the plasma membrane
To generate constructs of YFP-GPI and CFP-GPI targeted to the plas-
mamembrane (negative control) the sequences coding for PrP-YFP-GPI
and PrP-CFP-GPI, in the respective plasmids, were used as template for
the primers 5′-ctt aag ctt atc atg gcg aac ctt ggc tac tgg ctg ctg gcc ctc ttt
gtg act atg tgg act gat gtc ggc ctc tgc aaa aag cgg cca aag cct atg gtg agc
aag ggc gag-3′ (forward) and 5′-agt gga tcc tca tcc cac gat cag gaa-3′
(reverse). The forward primer contains the coding region for the
peptide signal that directs the protein to the ER and anneals with the
FP coding sequence. The resulting constructs YFP-GPI and CFP-GPI
were cloned into the plasmids pcDNA 5.0/Hyg and pcDNA 3.1/Zeo,
respectively.
2.1.4. Generation of CFP-YFP-GPI construct targeted to the plasma
membrane
To generate the construct CFP-YFP-GPI targeted to the plasmamem-
brane (positive control) the construct CFP-GPI was used as template to
replace the GPI-anchor sequence by the recognition site for the restric-
tion enzyme EcoRI using the primers 5′-ctt aag ctt atc atg gcg aac ctt ggc
tac-3′ (forward) and 5′-tat aat gaa ttc ctt gta cag ctc gtc cat-3′ (reverse).
The construct PrP-YFP-GPI ampliﬁed by PCR was subcloned into the
pGEM plasmid (Promega, USA) and then restricted with HindIII and
EcoRI to remove the PrP coding sequence. The CFP sequence, including
the peptide signal targeting to the ER, was then ligated to the pGEM
plasmid between HindIII and EcoRI to generate the construct CFP-YFP-
GPI. This construct was then subcloned into pcDNA5.0/Hyg between
HindIII and BamHI restrictions sites.
2.1.5. Generation of PrP-mtq2-GPI construct targeted to the plasma
membrane
The sequence of m-turquoise2 (mtq2) from the pmtq2 vector was
ampliﬁed using the primers 5′-ggg aga aga tcc agc atg gtg agc aag ggc-
3′ (forward) and 5′-gga tct ccc gtc ctt gta cag ctc gtc-3′ (reverse) and
digested with EcoRI and Bsp1407I (Thermo, Germany). After digestion,
the resulting sequence was ligated to the pGem vector containing PrP-
YFP-GPI to remove the YFP coding region. The newly formed PrP-
mtq2-GPI sequence in pGem was digested with HindIII and BamHI
and cloned into pcDNA 3.1/Zeo for mammalian expression.
2.1.6. Generation of mtq2-GPI constructs targeted to the plasmamembrane
To generate the construct of mtq2-GPI targeted to the plasma
membrane (negative control) the sequence coding for mtq2 from the
pmtq2 plasmid was used as template for the primers 5′-ctt aag ctt atc
atg gcg aac ctt ggc tac tgg ctg ctg gcc ctc ttt gtg act atg tgg act gat gtc
ggc ctc tgc aaa aag cgg cca aag cct atg gtg agc aag ggc gag-3′ (forward)
and 5′-gga tct tct ccc gtc ctt gta cag ctc gtc-3′ (reverse). The ampliﬁed
sequence was digested with HindIII and Bsp1407I. The forward primer
contains the coding region for the peptide signal that directs the protein
to the ER and anneals with the FP coding sequence. The resulting
construct was cloned into CFP-GPI-pcDNA 3.1/Zeo plasmid, digested
with HindIII and Bsp1407I, to replace the coding sequence of CFP with
that of mtq2.
2.1.7. Generation of mtq2-YFP-GPI construct targeted to the plasma
membrane
To generate the construct mtq2-YFP-GPI targeted to the plasma
membrane (positive control), the construct mtq2-GPI was used as tem-
plate to replace the GPI-anchor sequence by the recognition site for the
restriction enzyme EcoRI using the primers 5′-ctt aag ctt atc atg gcg aac
ctt ggc tac-3′ (forward) and 5′-tat aat gaa ttc ctt gta cag ctc gtc cat-3′
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into the pGEMplasmid (Promega, USA) and then restrictedwith HindIII
and EcoRI to remove the PrP coding sequence. The mtq2 sequence,
including the peptide signal targeting to the ER, was then ligated to
the pGEM plasmid between HindIII and EcoRI to generate the construct
mtq2-YFP-GPI. To generate a positive control with a linker between
mtq2 and YFP (residues GSLVPRGS), the sequence YFP-GPI was ampli-
ﬁed using the primers 5′-ttt tga att cgg tag tct ggt gcc gcg tgg tag
tat ggt gag caa ggg cga gga g-3′ (forward) and 5′-agt gga tcc tca tcc
cac gat cag gaa-3′ (reverse). This fragment was subcloned between
EcoRI and BamHI into the pGEM plasmid and then subcloned into
pcDNA5.0/Hyg between HindIII and BamHI restrictions sites. All con-
structs were veriﬁed by DNA sequencing.
2.2. Cell culture and transfection
N2a-BOS, PK1 and PK1 cell knockdown for PrP [13] were cultured
at 37 °C under 5% CO2 in Optimem I supplemented with 10% FBS,
100 μg/mL streptomycin and 100 U/mL penicillin (Invitrogen, USA).
Transfection of 1.5 × 105–3 × 105 N2a-BOS or PK1 cells was carried
out in 35 mm culture dishes with 1 μg of the appropriate plasmid
using Fugene 6 (Roche, Germany) according to the manufacturer's
protocol (1 μg DNA: 3 μL transfection reagent). Double transfections
were carried out at a ratio of 1:1 for the two plasmids. Transfections
occurred overnight and then cells were incubated in fresh medium.
After two days of transfection, stable clones of N2a-BOS cells were
selected for one month upon incubation with 250 μg/mL of
hygromycin and/or with 250 μg/mL of zeocin (Invitrogen, USA), for
constructs cloned in pcDNA5.0/Hyg or pcDNA 3.1/Zeo, respectively.
Stable clones expressing the constructs PrP-YFP-GPI and/or PrP-
CFP-GPI were then selected under the microscope. For live-cell
microscopy cells were cultured on glass bottom culture dishes
(MatTek, USA). For cell ﬁxation, these were treated with 3.7%
paraformaldehyde for 15 min and then washed with PBS. Cells
were infected with 10−3, 10−5 and 10−7 dilutions of prion infected
brain homogenate prepared in PBS (Rocky Mountain Laboratory
prion strain – RML – kindly provided by A. Aguzzi and P. Schwarz).
2.3. Western blot
Cells were grown until conﬂuence in 6 well plates, rinsed and resus-
pended in cold PBS. After centrifugation cells were lysed in RIPA buffer
(25 mM Tris–HCl, pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate and 0.1% SDS) with freshly added 2 mM of PMSF
(phenylmethylsulphonyl ﬂuoride), 10 mM of MgCl2, 50 μg/mL DNase
and 1 μg/mL RNase. Total protein samples (240 μg) digested and non-
digested with PNGase (2U) (Sigma, Germany) were separated in 12%
SDS-PAGE electrophoresis, transferred to a nitrocellulose membrane
for 1 h, blocked overnight with 4% non-fat dry milk in TBST (25 mM
Tris–HCl, pH 7.4, 3 mM KCl, 140 mM NaCl and 0.05% Tween 20), incu-
bated with 3F4 or POM1 anti-PrP mAbs for 1 h, incubated with Alexa
Fluor 488 tagged goat anti-mouse Ab and imaged with a Typhoon Trio
scanner (GE Healthcare, USA). Infected or healthy homogenized
mouse brain – 1 μL of 20% (wt/vol) – was diluted in 30 μL of Triton-
doc buffer supplemented with DNase and RNase and digested with
10 μg/mL proteinase K for 1 h at 37 °C. The reaction was stopped with
the addition of 3 mM of PMSF and the samples were analyzed by
western blot.
2.4. Immunocytochemistry
Neuroblastoma cells grown on glass coverslips were rinsed brieﬂy
with PBS, ﬁxed and permeabilized with cold methanol (−20 °C) for
10 min and then washed twice with PBS, before blocking with 1% BSA
in PBS for 30 min. Cells were washed three times and then incubated
with the mouse anti-PrP monoclonal antibody POM1 in PBS/1% BSA,for 1 h at RT. Following three additional washes in PBS, cells were
incubated with Alexa Fluor 647-labeled goat anti-mouse IgG1 second-
ary antibody diluted in PBS/1% BSA, for 1 h at RT in the dark. Cells
were washed again in PBS, counterstained for 5 min with Hoechst
33342 (Invitrogen), rinsed with PBS andmounted onmicroscopy slides
using Mowiol as mounting medium.
2.5. Cell treatment with phosphatidylinositol-speciﬁc phospholipase C
To release GPI-anchored proteins from the plasma membrane
cells were washed with cold PBS and incubated with 1 U/mL of
phosphatidylinositol-speciﬁc phospholipase C (PIPLC, Invitrogen)
in PBS at 37 °C for 2 h. Fluorescence emission spectra of the incubation
buffer were recorded in a Fluoromax 4 using excitation at 410 nm for
CFP and at 488 nm for YFP.
2.6. Cell-infectivity assays
PK1 or the stable cell clone expressing the constructs PrP-YFP-GPI
and PrP-CFP-GPI was seeded in 24-well plates and cultured until
reaching 70% conﬂuence. After 16 h, the cells were exposed to fresh
mediumcontaining a 10−3 dilution of RML 10% infectious brain homog-
enates. Non-infected brain homogenates were used as controls. Three
days later the media was renewed before splitting 1:10. After 3 more
splits the cellswere transferred to a 6-well plate and grownuntil conﬂu-
ence. For immunoblotting detection of PrPSc, the cell cultures were
rinsed with cold PBS and solubilized in RIPA buffer for 15 min at 4 °C.
The lysate was clariﬁed (11,000 g, 5 min) and the protein content in
the supernatant was quantiﬁed using the Bradford method. Samples
were digested with 1.2 μg of proteinase K per mg of protein for
45min at 37 °C, stopped by the addition of 3mMof PMSF and analyzed
by western blot using the mAb POM1.
2.7. Microscopy
Steady-state ﬂuorescence images were acquired with an inverted
Carl Zeiss Axio Observer.Z1 mounted LSM710 confocal microscope
with spectra detection (Carl Zeiss, Germany) using a 63× plan-
apochromatic 1.4 NA oil immersion objective and a 25 mW argon
laser. The microscope is equipped with a live cell imaging chamber
with temperature and CO2 control. CFP was excited at 458 nm and the
emission was detected from 460 to 490 nm and YFP was excited at
514 nm and detection was from 530 to 600 nm. FRET channel for sensi-
tized emission uses excitation at 458nmand emission between 530 and
600 nm. The CFP and FRET channels were acquired simultaneously.
Measurements of ﬂuorescence lifetime imaging microscopy (FLIM)
were performed using a time-resolved ﬂuorescence microscope
(MicroTime 200, PicoQuant GmbH). A detailed description may be
found elsewhere [18]. The excitation source is a pulsed diode laser
emitting at 405 nm with a repetition rate of 20 MHz. Illumination and
collection of light were done through a water immersion objective
60× magniﬁcation with NA of 1.2 (UPLSAPO 60XW, Olympus). The
emitted ﬂuorescence was spectrally selected by bandpass ﬁlters with
transmission in the intervals 465–495 nm (donor channel, mtq2) and
528–563 nm (acceptor channel, YFP). Detection was done with single-
photon counting avalanche diodes (Perkin-Elmer) and digitized by
TimeHarp 200 TC-SPC PC board (PicoQuant GmbH). The instrument re-
sponse function (IRF) has a FWHM around 0.8 ns and a time increment
of 38 ps/channel. Typically, ﬂuorescence lifetime image scanswere per-
formed over an area of tens of μm2 with a resolution of 0.15 μm/pixel
and an integration time of 2 ms/pixel. Decay ﬁtting was performed by
reconvolution with the IRF using a nonlinear least-squares procedure
based on theMarquardt algorithm. The quality of the ﬁts was evaluated
by the usual criteria for the χ2 parameter and by visual inspection of the
weighted residuals.
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2.8.1. Acceptor photobleaching
For acceptor photobleaching FRET measurements on ﬁxed cells, a
region of interest (ROI) was bleached in the YFP channel using 20 inter-
actions with 100% laser power at 514 nm. Pre- and post-bleach images
were acquired in the CFP and YFP channels. Images were also acquired,
for cells expressing CFP and YFP constructs only, to measure non-
speciﬁc CFP bleaching and discard YFP to CFP photoconversion.
FRET efﬁciency was calculated according to:
E ¼ Ipost bleachCFP –Ipre bleachCFP
 
=Ipost bleachCFP ð1Þ
where ICFP is the ﬂuorescence intensity of CFP.
2.8.2. Fluorescence lifetime imaging microscopy
FRET efﬁciency was calculated based on the ﬂuorescence lifetime of
the donormtq2 in the absence (τD) and presence of acceptor YFP (τDA):
E ¼ 1−τDA=τD: ð2Þ
2.8.3. Sensitized-emission
For each experiment, cells with donor only (CFP), acceptor only
(YFP) and both donor and acceptor were used to account for changes
in donor and acceptor bleed-through depending on optical parameters.
A set of three images of the same ﬁeld was taken using CFP, YFP and
FRET channel settings. A binary mask was created on the stack of the
three images to select all the ﬂuorescence at the surface of the cell,
corresponding to ﬂuorescent proteins attached to the cell membrane.
Then, original images were multiplied by the binary image to keep
pixel intensities unchanged at the ﬂuorescent cell surface and convert
pixel intensities to zero outside the ROI deﬁned by the mask. After this
treatment, FRET images were calculated as described below and
represented in a rainbow scale using the Zen software from Carl Zeiss.
Sensitized-emission FRET index was calculated as follows:
FRETi ¼ IDA DAð Þ–IDA Dð Þ=IDD Dð Þ  IDD DAð Þ–IDA Að Þ=IAA Að Þ  IAA DAð Þ: ð3Þ
This equation follows the nomenclature used by Zal and Gascoigne
[24]. First and second letters as subscript refer to excitation and
emission settings, respectively, D for donor and A for acceptor. Letters
between parentheses refer to the presence of donor (D), acceptor (A)
or donor and acceptor (DA). IDA(DA) is the intensity of the donor in the
acceptor channel for cells with donor and acceptor — FRET channel.
IDD(DA) and IAA(DA) are the intensities of the donor in the donor channel
and of the acceptor in the acceptor channel, respectively, for cells with
both donor and acceptor. IDA(D)/IDD(D) is the intensity of the donor in
the acceptor channel divided by the intensity of the donor in the
donor channel for cells with donor only — donor bleed-through mea-
sured to be constant for speciﬁc optical parameters as expected [25]. A
value of 0.30–0.41 was measured for donor bleed-through depending
on the optical parameters used. IDA(A)/IAA(A) is the intensity of the
acceptor in the acceptor channel upon excitation with donor wave-
length divided by the intensity of the acceptor in the acceptor
channel for cells with acceptor only — direct excitation of the acceptor
with donor wavelength also called acceptor bleed-through. Acceptor
bleed-through was constant for each speciﬁc combination of optical
parameters, ranging from 0.12 to 0.58 for the different optical parame-
ters used in this work. Bleed-through coefﬁcients for CFP and YFP were
determined independently for each experiment and were found to be
remarkably constant across a wide range of concentrations in cells
[24]. The intensity of donor using acceptor excitation and emission
settings (IAA(D)) is zero as well as the intensity of the acceptor using
donor excitation and emission settings (IDD(A)).Sensitized-emission live FRET imaging leads to a FRET index
which is dependent on the ﬂuorophore concentration and the optical
parameters of the imaging system in use. Dependence on ﬂuorophore
concentration, intensity and variation of spectral bleed-through as a
function of ﬂuorophore intensity may be corrected using normalized
FRET (NFRET) with the PixFRET plug-in of ImageJ [26]. However,
NFRET is still a non-absolute value dependent on the optical parameters
preventing quantitative evaluation, comparison and standardization of
FRET imaging data. To overcome this disadvantage Zal and Gascoigne
[24] have proposed a methodology to calculate FRET efﬁciency (E-FRET)
as a quantitative measure independent of the optical parameters of the
imaging system. E-FRET correlates with the degree of donor–acceptor
interaction or clustering. The E-FRET was calculated using normalized
FRET:
E‐FRET ¼ NFRET= NFRETþ Gð Þ ð4Þ
where NFRET= FRETi/SQRT(IDD(DA) ∗ IAA(DA)) and G is a correlation factor
between the sensitized-emission and the concomitant drop in donor
ﬂuorescence experimentally determined according to:
G ¼ FRETi–FRETpost bleachi
 





The parameter Gwasmeasured on ﬁxed cells, to prevent diffusion of
ﬂuorescent proteins into bleached regions, and a value of 1.7 ± 0.2 was
obtained.
2.9. Statistical analysis
Results on plots are expressed as mean ± standard deviation




Neuroblastoma cells were transfected with constructs containing
the full length mouse PrP at the N-terminal followed by a ﬂuorescent
protein and the coding region for the GPI-anchor peptide signal at the
C-terminal. The full length PrP ORF includes the coding region for the
peptide signal that directs the protein to the ER but not the coding re-
gion that signals anchorage to the cell membrane through the GPI
group, which was placed after the ﬂuorescent protein. To have a FRET
pair two different constructs were designed, one with CFP and the
other with YFP (named PrP-CFP-GPI and PrP-YFP-GPI, respectively).
Using these constructs, we expected to have the prion protein attached
to the cell membrane through a GPI-anchored ﬂuorescent protein.
N2a-BOS cells were transfected with one construct only or with
both constructs sequentially and plasmid resistance markers were
used to select a stable cell line, expressing one or two fusion proteins
attached to the cell membrane. Selection of stable clones intended to
minimize cell-to-cell and experiment variability due to different
transfection efﬁciencies, variable transcriptional activity and variable
cell substructure localization [27]. Stable clones were selected under
the microscope and analyzed with confocal ﬂuorescence microscopy
(Fig. 1). Fluorescence from CFP and/or YFP was clearly detected at the
cellmembrane as expected, due to the presence of the peptide signaling
the protein to the ER and the peptide signaling for GPI-anchoring. The
double clone shows colocalization of the two fusions PrP-CFP-GPI and
PrP-YFP-GPI, despite some spreading towards CFP or YFP channels
(Fig. 1C). Fluorophore colocalization is diffraction limited and therefore
gives no information on FRET relevant distances but paves the way to
eventually detect FRET. Colocalization plots showing pixel spreading
are assigned to partial colocalization [28]. In our study, pixel spreading




CFP channel YFP channel Merge Colocalization
A) B)
CFP channel YFP channel
Fig. 1. Stable clones expressing the fusions PrP-CFP-GPI (A), PrP-YFP-GPI (B) and both PrP-CFP-GPI and PrP-YFP-GPI (double clone) (C). Colocalization for the fusions PrP-CFP-GPI and PrP-YFP-GPI
is shown in the plot in (C) with a Pearson's coefﬁcient of 0.75. (D) Cell substructure of the double clone showing the nuclei labeled with Hoechst 33342 in blue and the ER labeled
with ER-tracker red in red (left panel). The image on the right shows a tridimensional view of the double clone, obtained after deconvolution and SFP rendering with the Huygens
software (SVI, The Netherlands), to highlight the non-homogeneous distribution of ﬂuorescent proteins on the membrane where clusters of ﬂuorescent proteins are visible in
green. The ER is shown in red. (E) Neuroblastoma cells (left panel PK1 and right panel PK1 knockdown cells) stained with mouse anti-PrP monoclonal antibody POM1 and Alexa
Fluor 647-labeled goat anti-mouse IgG1 for endogenous PrP (red) and counterstained with Hoechst 33342 for nuclei (blue). Scale bars correspond to 5 μm.
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other regions richer in PrP-YFP-GPI. Cell substructure for the double
clone was highlighted through nuclei and ER labeling using the
ﬂuorophores Hoechst 33342 and ER-tracker red (Molecular Probes),
respectively (Fig. 1D, left panel). Non-homogeneous distribution of
ﬂuorescent proteins was clearly observed in the three-dimensional
view of the cellmembrane showing regionswhere clusters of ﬂuorescent
proteins occur (Fig. 1D, right panel). Whether this clustering relates to
membranemicrodomains such as caveolae or lipid rafts remains to bede-
termined, namely because their size seems to be beyond the resolution of
light microscopy [19]. Despite recent developments to characterize
membrane microdomains, such as photonic force microscopy and single
molecule microscopy, controversy still remains and size estimates for
these microdomains range from 26 nm to around 700 nm [29,30]. Large
microdomains substructure may result from dynamic assemblies of
individual rafts [29,31]. Nevertheless, protein clustering on membrane
microdomains has been detected using FRET measurements to near-
Angstrom sub-diffraction resolution [19,32,33]. Membrane microdo-
mains which form in the exoplasmic leaﬂet of cellular membranes can
selectively incorporate protein and thereby result in protein–protein
and protein–lipid interactions [31]. The pattern of ﬂuorescencedistribution in the transfected clones matches the pattern of endoge-
nous PrP localization in neuroblastoma cells as shown in the left panel
of Fig. 1E where endogenous PrP was stained with the anti-PrP mono-
clonal antibody POM1 [34]. The monoclonal POM1 antibody recognizes
helix 1 in the globular C-terminal domain of PrP.
To certify that fusion proteins were properly processed during cell
trafﬁcking and no truncation occurred, the size of the fusion proteins
was analyzed by western blot using two antibodies against PrP
(Fig. 2A). The monoclonal antibody 3F4 does not react with mouse PrP
as it speciﬁcally requires two Met residues at positions 108 and 111
[35]. This epitope was introduced into the fusion proteins by site-
directed mutagenesis of Leu108 and Val111 to distinguish the fusion
PrP-FP from the endogenous PrPC present in N2a-BOS cells. The double
clone shows three bands slightly above 50 kDa detected with both 3F4
and POM1 antibodies. These three bands have the expected size for
the fusion PrP-FP (50.7 kDa) indicating no protein truncation during
cell trafﬁcking. The three bands are obviously absent in the original
N2a-BOS cells and in PK1 neuroblastoma cell knockdown for PrP [13].
The presence of three bands results from different degrees of glycosyla-
tion as they shifted to a single band at smaller size after treatment with
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Fig. 2. (A)Western blot analysis using themonoclonal antibody 3F4 (left panel) and themonoclonal antibody POM1 (two right panels). The lower panel for POM1 shows the same region
between 37 and 20 kDa, as the above but the image was acquired at higher PMT voltage to better identify the bands for endogenous PrP. N2a-BOS cells (lane 1); double clone expressing
the two fusions PrP-CFP-GPI and PrP-YFP-GPI (lane 2); PK1 neuroblastoma cell knockdown for PrP (lane 3); N2a-BOS cells treatedwith PNGase (lane 4); double clone treatedwith PNGase
(lane 5); PK1 neuroblastoma cell knockdown for PrP treated with PNGase (lane 6). (B) Merged ﬂuorescence and phase contrast images comparing cells of the double clone non-treated
(left image) and treated with PIPLC (right image). Note that intracellular inclusions richer in CFP (red channel) remain after treatment with phospholipase C. The plot on the right shows
theﬂuorescence emission spectra of CFP (gray spectrum) and YFP (black spectrum) of the PBS buffer after PIPLC activity and the inset shows thewestern blot of the same bufferwhere the
band of PrP-FP is detected.
986 E. Tavares et al. / Biochimica et Biophysica Acta 1842 (2014) 981–991The antibody POM1 recognizes both the endogenous PrP and the fu-
sions PrP-FP-GPI (Fig. 2A, two right panels). Glycosylation of endoge-
nous PrP was completely removed after PNGase treatment but the
same treatment was not enough to completely deglycosylate the fu-
sions PrP-FP-GPI as two bands around 50 kDa persisted. The western
blot using POM1 also revealed that the expression levels of the fusion
PrP-FP were considerably higher compared to the endogenous PrP.
Within the same gel lane, strong bands for endogenous PrPwere clearly
seen only at the cost of saturating the bands for the fusion PrP (bottom
panel of Fig. 2A). Endogenous PrPwas absent in PK1 neuroblastoma cell
knockdown for PrP used as negative control. To probe the GPI-anchor of
the fusion proteins cells were incubated with PIPLC known to release
PrP from the cell membrane [9]. Cell treatment with PIPLC released all
the ﬂuorescence from the cell surface, proving that PrP-FP fusions are
tethered to the cell membrane through a GPI-anchor (Fig. 2B). The ﬂuo-
rescence emission of the supernatant was analyzed and CFP and YFP
ﬂuorescence was clearly detected as shown in the right plot of Fig. 2B.
Western blot analysis of the same supernatant shows the band corre-
sponding to the fusions PrP-FP (inset in Fig. 2B, right plot).3.2. Acceptor photobleaching FRET measurements on ﬁxed cells
Thedouble clone, expressing the fusions PrP-CFP-GPI andPrP-YFP-GPI,
was screened for FRET that could result from clustering of GPI-anchored
proteins in membrane microdomains. Acceptor photobleaching FRET
was ﬁrst tried in cells transiently expressing both fusions that were
ﬁxed to avoid diffusion of new proteins into the bleached region during
scanning. Fluorescence intensity of CFP increases after YFP bleaching as
clearly shown in Fig. 3A. Non-bleaching of YFP in the control region
leads to a very small decrease in the ﬂuorescence of CFP and YFP,
probably due to non-speciﬁc bleaching during the ﬁrst scan (dashed
control ROI and dashed columns in the plot of Fig. 3A). The increase in
CFP ﬂuorescence after YFP bleaching reﬂects a FRET efﬁciency thatranged from zero to around 20% for different locations on the mem-
brane (Fig. 3B). FRET efﬁciency measured by acceptor photobleaching
displayed a large heterogeneity of values depending on the local
concentration of acceptor molecules, as previously reported [19,36]. In-
deed, FRET efﬁciency increases when the density of acceptor molecules
increases, as the excited donor has a higher probability to transfer ener-
gy to a neighboring acceptor [22]. Only if all donor and acceptor mole-
cules are clustered in small submicron-size membrane domains FRET
efﬁciency becomes independent of acceptor density [14,19,36]. Howev-
er, it seems that only 20 to 40% of GPI-anchored proteins are organized
as clusters [33]. The distribution pattern of FRET efﬁciency versus accep-
tor concentration can be used to draw conclusions on protein clustering
at the cell surface [15,19,36]. Fig. 3B also shows the acceptor
photobleaching FRET data for a positive control, consisting of a fusion
between CFP and YFP GPI-anchored. This control reﬂects 100% cluster-
ing and shows that FRET is independent of acceptor concentration as
expected [37]. A negative control expressing the fusions CFP-GPI and
YFP-GPI (no PrP) and cells expressing both fusions containing PrP
(PrP-CFP-GPI and PrP-YFP-GPI) displayed the typical saturation curve
expected for partly clustered proteins. This saturable isotherm was
ﬁtted to the hyperbolic function to conclude on the degree of clustering
[19]:
E% ¼ E%max F= Fþ Kð Þ
where F is the ﬂuorescence intensity of the acceptor and K is analogous
to a dissociation constant providing a parameter for the degree of clus-
tering. The ﬁt for the negative control (no PrP) gave a K value of
8741 a.u., whereas for the cells expressing both fusions containing PrP
the K value was of 7429 a.u. This indicates that the presence of PrP
leads to increased clustering of GPI-anchored proteins resulting from
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Fig. 3.Quantitative FRET images on the membrane of cells. (A) FRET images for acceptor photobleaching in ﬁxed cells transiently transfected to express the fusions PrP-CFP-GPI
and PrP-YFP-GPI. The solid rectangle shows the ROI subjected to YFP photobleaching and the dashed rectangle shows the control ROIwith no photobleaching. The plots below the images
showCFP and YFP ﬂuorescence intensities for the photobleached (left plot) and the non-photobleachedROIs (right plot).White columns refer to pre-photobleaching and gray columns to
post-photobleaching. The acceptor photobleaching experiment shown in the plot gave a FRET efﬁciency of 20% but FRET values change considerably for different locations in the
membrane as shown in (B) where acceptor photobleaching FRET measurements were carried out on ﬁxed cells, transiently transfected with: the fusion CFP-YFP-GPI — positive control
(left plot); the fusions CFP-GPI and YFP-GPI— negative control (center plot) and the fusions PrP-CFP-GPI and PrP-YFP-GPI (right plot). The solid line for the positive control shows a linear
equation ﬁt to highlight the independence of FRET on acceptor intensity. Solid lines for the negative control and for cells expressing the fusions PrP-CFP-GPI and PrP-YFP-GPI show a
hyperbolic function (E% = E%maxF / (F + K)) giving E%max values of 22 and 23% and K values of 8741 and 7420 a.u., respectively.
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FLIM on ﬁxed cells was used to conﬁrm intermolecular FRET be-
tween both fusions containing PrP. FLIM offers several advantages com-
pared to steady-state FRET [16]. FRET efﬁciency is independent of the
excitation intensity and of unintended photobleaching and bleed-
through corrections are avoided. The ﬂuorescence lifetime of the
donor decreases when the acceptor is in close proximity (b100 Å) due
to the contribution of the resonance energy transfer pathway to donor
decay. However, CFP is not a suitable FRET donor for FLIM due to the
complexity of its decay displaying two lifetimes and to the short average
lifetime [18,37]. Therefore, CFP was replaced by the appropriate mtq2
that decays with a single-exponential, longer lifetime of 3.8–4 ns [37].
Intermolecular FRET betweenmtq2 and YFP was conﬁrmed by compar-
ing the ﬂuorescence lifetime on membranes of cells expressing mtq2-
GPI only or PrP-mtq2-GPI and PrP-YFP-GP (Fig. 4). The single lifetime
of mtq2 in the absence of YFPwasmeasured to be 3.8± 0.2 ns (number
of ROIs ≥20) in exact concordance with the value previously reported
[37] as shown in Fig. 4A and D. Orange bars in Fig. 4G show some life-
time dispersion around the average of 3.8 ns probably reﬂectingheterogeneous membrane environments. The decay of mtq2 in the
presence of YFP remains single exponential with a lifetime of 3.5 ±
0.2 ns (Fig. 4B, E and G). The still single-exponential feature of the
mtq2 decay in the presence of the acceptor YFPmeans that lifetime dis-
crimination between donors transferring and non-transferring energy
to YFP is not possible. The average lifetime of 3.5 ± 0.2 ns (green bars
in Fig. 4G) results from a FRET efﬁciency of 8.1± 6%. This valuematches
the 10% FRET efﬁciency between CFP-GPI and YFP-GPI measured by
FLIM on CHO-K1 cells [38] and is perfectly within the range of values
measured in our work by acceptor photobleaching (Fig. 3B) and
sensitized-emission on live cells (see data below). The lifetime of
mtq2 in the positive control (fused to YFP with the linker GSLVPRGS
in between) was 3.2 ± 0.2 ns (Fig. 4C, F and G) resulting from a FRET
efﬁciency of 16 ± 5%, also perfectly within the range measured by ac-
ceptor photobleaching and sensitized emission. FLIM measurements
carried out in our cell system were unable to distinguish between the
population of molecules placed at FRET and non-FRET relevant
distances as ﬂuorescence decays remain single-exponential but they
provide an independent prove that FRET occurs between our ﬂuores-
cent proteins GPI-anchored to the cell membrane. Based on their
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Fig. 4. FLIM images and ﬂuorescence decays for ﬁxed cells expressing transiently the
fusion mtq2-GPI (A and D), the fusions PrP-mtq2-GPI and PrP-YFP-GPI (B and E) and
the fusionmtq2-YFP-GPI used as positive control (C and F). The lifetime scale for both
images is shown on the left and white bars correspond to 10 μm. Fluorescence decays
shown in D, E and F were obtained from the regions of interest shown in images A, B
and C as dashed white boxes. The weighed residuals from the respective single exponential
ﬁts are shown above the decays. (G) Lifetime histograms from ﬂuorescence decays collected
from ≥20 ROIs of interest over 5 image scans on cells expressing only mtq2-GPI (orange
bars), expressing the two constructs PrP-mtq2-GPI and PrP-YFP-GPI (green bars) and
expressing the fusion mtq2-YFP-GPI (cyan bars).
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also provided an independent proof for FRET efﬁciencies measured by
acceptor photobleaching and sensitized emission.
3.4. Live-cell sensitized emission FRET measurements
Live-cell sensitized emission FRET was then measured in the stable
clone expressing both fusions, after selecting all the surface of the cell
as ROI. The average absolute efﬁciency of FRET was calculated for all
the cell membrane according to Zal and Gascoigne [24] and data is
shown in Fig. 5. These E-FRET sensitized-emission values were signiﬁ-
cantly more consistent than the majority of values measured by accep-
tor photobleaching for cells transiently expressing both fusions because
they reﬂect average FRET efﬁciency for all the cell membrane. Also, PrP
expression in the stable clone was lower but more constant between
cells. Live-cell sensitized emission FRET was measured for cells in the
absence and presence of a 10−3 dilution of non-infected and prion in-
fected brain. E-FRET values at the cell surface showed an increase in
the number of green to red pixels in the presence of prion-infected
brain (Fig. 5A and B). This indicates that the presence of exogenous
prions promoted the clustering of the prion protein at speciﬁc locations
of the cell surface leading to an increase in FRET efﬁciency. Heterogene-
ity of FRET efﬁciencies at the cell surface, reﬂected in pixels with distant
scaled-colors, is expected especially in the presence of exogenousprions
which should interact with speciﬁc locations in the membrane. In fact,differences in energy transfer between different cells, different ROIs or
even pixels should represent different local densities of acceptor- and
donor-labeled molecules within clusters, as referred above and ob-
served in other reports [14,32]. Therefore, to clearly distinguish and
quantify FRET efﬁciencies between cells in the absence and presence
of prions, all the ﬂuorescent surface of the cell membrane was selected
as ROI and average intensities were used to calculate absolute E-FRET
values (Fig. 5C). We have measured E-FRET on a signiﬁcant number of
cells (12 b n b 35) but plotted only the top 50% values. This criterion
was applied equally to all situations (no brain, non-infected brain and
prion-infected brain) and is justiﬁed by the fact that not all the cells
are in contact with exogenous prions and PrP expression levels change
from cell-to-cell, even in the stable clone. Indeed, recent work reports
that up to 30% of cells in culture were infected in the presence of exog-
enous prions [13]. Plotting the top 50% values compares cells that may
be more sensitive to increased clustering, leading to a more representa-
tive analysis of the events. Nevertheless, plotting 100% of the values
measured does not change the pattern nor the conclusions taken (see
Supplementary material S1). FRET efﬁciency increased from 3.9 to
4.5% to 7% in the presence of a 10−3 dilution of exogenous prions one
day after infection. When 10−5 or 10−7 dilutions of prion-infected
brain were used the E-FRET values obtained were 4.4 and 4.5%, respec-
tively. The increase in FRET efﬁciency in the presence of a 10−3 dilution
of prion-infected brain was statistically signiﬁcant, conﬁrming the clus-
tering of the prion protein at the cell surface induced by prions. After
three days of infection, E-FRET values increased slightly for all condi-
tions and the E-FRET value in the presence of a 10−3 dilution of the
prion-infected brain was still higher than in the other conditions (8.3%
compared to 4.8–6.3%). Clustering of lipid-modiﬁed proteins on mem-
branes was previously detected for GPI-anchored GFP and for fusions
of CFP and YFP with short peptides containing sequences for acylation
and prenylation [19,33,39]. Average FRET efﬁciency increased signiﬁ-
cantly to 10% in neuroblastoma live-cells transiently transfected, due
to the large amounts of PrP-FP-GPI attached to the cell membrane
(Fig. 5D). E-FRET sensitized-emission values increased from 10 to 11%
to 16% in the presence of a 10−3 dilution of prion-infected brain,
reﬂecting an increased clustering in the presence of exogenous prions
as observedwith the stable cell clone. This range of E-FRET values, espe-
cially the 16% measured in the presence of exogenous prions, reﬂects a
high degree of clustering as the positive control, consisting of a fusion of
CFP and YFP GPI-anchored (CFP-YFP-GPI construct), displayed 17% of
FRET efﬁciency (Fig. 5D). To address the effect of the prion protein on
protein clustering measured by live-cell sensitized emission, the nega-
tive control consisting of cells transiently transfected with the fusions
CFP-GPI and YFP-GPI attached to the cell membrane was analyzed
(Fig. 5D). This negative control also showed some degree of FRET due
to clustering of GPI-anchored proteins on rafts, as shown above by ac-
ceptor photobleaching and reported previously for GFP-GPI using
homo-FRET measurements [33]. However, E-FRET values for this nega-
tive control were slightly lower than the values measured for the fu-
sions containing PrP, reﬂecting interactions between neighbor PrP
molecules that may occur to increase the degree of protein clustering
at the cell surface. Clustering of GPI-anchored proteins seems to be rath-
er loose and/or transient [39] and PrP intermolecular interactionsmight
induce tighter or long-lived protein clustering. More interestingly, the
presence of exogenous prions did not increase E-FRET values for the
negative control and therefore did not promote protein clustering.
Protein clustering at the cell surface induced by exogenous prions only
occurred for the GPI-anchored prion protein as part of the fusion pro-
tein, hence it must result from a speciﬁc interaction between infectious
prions and the GPI-anchored prion protein.
3.5. Cell-infectivity assays
Cell-based infectivity assays were developed for mouse scrapie
prions based on the resistance of PrPSc to PK digestion [40]. We have
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Fig. 5. Quantitative FRET images at the surface of live cells expressing the fusions PrP-CFP-GPI and PrP-YFP-GPI, CFP-GPI and YFP-GPI used as negative control and CFP-YFP-GPI
only. (A) Quantitative FRET images using sensitized emission in live cells stably expressing the fusions PrP-CFP-GPI and PrP-YFP-GPI in the presence of a 10−3 dilution of non-infected
brain. (B) Quantitative FRET images using sensitized emission in live cells stably expressing the fusions PrP-CFP-GPI and PrP-YFP-GPI in the presence of a 10−3 dilution of prion-
infected brain. The ROI where E-FRET was calculated is shown only in the FRET channel for visual clarity. The E-FRET image is shown in a rainbow pseudocolor scale. (C) Plot with the
absolute E-FRET values for the stable double clonemeasured in the absence of the brain, presence of a 10−3 dilution of non-infected brain and presence of 10−3, 10−5 and 10−7 dilutions
of prion-infected brain. Light gray bars refer to the stable clone one day after infection and dark gray bars refer to the stable clone three days after infection. The inset shows the western
blot for the infected brain (left lane) and non-infected brain (right lane) after PK digestion. (D) Plot with the absolute E-FRET values for cells transiently transfected in the absence of the
brain, presence of a 10−3 dilution of non-infected brain and presenceof a 10−3 dilution of prion-infected brain. Light gray bars refer to cells transiently transfectedwith the constructs CFP-
GPI and YFP-GPI (negative control), dark gray bars refer to cells transiently transfected with the constructs PrP-CFP-GPI and PrP-YFP-GPI and the single black bar refers to the positive
control transiently transfected with the fusion CFP-YFP-GPI. The number of cells analyzed was 12 b n b 35 but only the top 50% E-FRET values were plotted for all conditions (no
brain, non-infected brain and prion-infected brain). ***The mean difference is signiﬁcant at the level p b 0.001.
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from RML mouse prions using the highly susceptible PK1 neuroblasto-
ma cell line as positive control [13]. Fig. 6 shows that our cell clone is
unable to propagate RML mouse prions at least at detectable amounts
compared to the susceptible PK1 cells. The presence of the three
bands of PrPSc resistant to PK was detected on infected PK1 cells only
and even the endogenous PrP present in our stable cell clone has not
acquired resistance to PK. The stable ﬂuorescent cell clone selected
probably originates from a non-susceptible N2a cell clone which
would explain why the endogenous PrP was unable to propagate
infectivity.
4. Discussion
Intermolecular FRET for GPI-membrane anchored proteins was
previously detected including with FLIM measurements [33,38]. In thiswork, we probed intermolecular FRET between GPI-anchored ﬂuores-
cent proteins fused to the prion protein. FRETwas unequivocally probed
by acceptor photobleaching of YFP acting as acceptor from CFP (Fig. 3)
and by FLIM of the suitable mtq2 acting as donor to YFP (Fig. 4).
Live-cell intermolecular FRET was then measured for the pair PrP-
CFP-GPI-anchored and PrP-YFP-GPI-anchored. Sensitized-emission
was used to perform live-cell FRET in order to avoid phototoxicity due
to bleaching. Using all the ﬂuorescent surface of the cell as ROI we
aimed at probing clustering of the prion protein attached to the cell
membrane. The analysis of cells expressing both fusions with the
prion protein compared to cells expressing CFP-GPI-anchored and
YFP-GPI-anchored only (negative control with no PrP) showed that
the presence of PrP increases slightly the clustering of GPI-anchored
proteins (Figs. 3 and 5). Interaction between neighbor PrP molecules
may promote clustering of GPI-anchored proteins. This interaction
might be physiologically relevant despite the higher expression levels
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Prion infect. brain
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Fig. 6.Western blot analysis using the monoclonal antibody POM1. PK1 cells (lanes 1–4);
double clone expressing the two fusions PrP-CFP-GPI and PrP-YFP-GPI (lanes 5–8). Note
the appearance of PK resistant PrPSc detected after three splits in PK1 cells incubated
with a 10−3 dilution of RML prion infected brain (lane 4) and its absence for the
double clone (lane 8). The band appearing above 50 kDa for PK1 cells (lanes 1 and 3) is
a non-speciﬁc band from the mAb POM1.
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prion proteinwas shown to dimerize in a GPI-dependentmanner at the
plasma membrane and dimer formation was implicated in the stress-
protective activity of PrP [41]. Additionally, we have observed that our
cells compared to the parental N2a-BOS cells adhere much strongly to
the surface of the culture ﬂask, indicating that our fusions containing
PrP may be functional at least regarding cell adhesion (see Supplemen-
tary material S2). Stronger adhesion is certainly related to the proposed
function of PrP on cell adhesion [42].
Moreover, this study shows that exogenous infectious prions
promote clustering of the FP-GPI-anchored prion protein (Fig. 5). This
process ought to represent the initial step of prion infectivity. Despite
the observation that our stable cell line is unable to propagate infectivity
as no PrPSc resistant to PK digestion is accumulated (Fig. 6), it seems
tempting to establish a direct correlation between increased clustering
of PrP in the presence of exogenous prions and the mechanism of
prion conversion. Transgenic mice, as well as chronically infected cell
cultures, expressing PrP tagged at its amino terminus with GFP were
shown to support prion replication [43]. Moreover, our data corrobo-
rates the current view on the mechanism of prion infectivity. Firstly, it
was shown that the plasma membrane is the primary site for prion
conversion [13]. Secondly, soluble PrPSc oligomers caused synapse
damage via clustering of syalylated GPI-anchors attached to PrP [10].
The sialic acid modiﬁcation, which is a rare modiﬁcation of mammalian
GPI-anchors, seems tomodify themembranemicroenvironment (rafts)
surrounding clustered PrP molecules resulting in aberrant activation of
phospholipase A2 and synapse damage. Using an independent live-cell
biophysical approach based on FRET, we were able to support these
two recent observations regarding the initial step of prion infectivity:
infectious prions interact with PrP at the plasmamembrane and this in-
teraction results in an increased clustering of the GPI-anchored prion
protein. These two observations help to elucidate the pathogenic cas-
cade underlying prion diseases. One of the downstream steps that
were identiﬁed recently consists in the persistent repression of protein
translational rates through phosphorylation of the translational initia-
tion factor eIF2α. This is nomore than a persistent unchecked activation
of the ER unfolded protein response leading to neurodegeneration [44].
The concentration of clustered molecules within a membrane plane is
thought to be an important element for signaling [45] and the prion
protein has been associatedwith several signalingmolecules such as ty-
rosine kinase [46], protein kinase A [47] and cytoplasmic phospholipase
A2 [48]. According to the common view that individual rafts cluster to-
gether to connect raft proteins and interacting proteins into signaling
complexes [45], increased PrP clustering may interfere with signaling
cascades.The prion protein is necessary for prion replication but to a large ex-
tent dispensable for the host. Therefore, screening for compounds that
decrease levels of cell-surface PrP has been used to select for antiprion
agents [49]. FRET measurements between antibodies labeled with
donor or acceptor were used to assess PrP expression levels making
the screen expensive and labor consuming. The novel cell system
based on live-cell FRET measurements, established in this work, allows
for direct readouts proportional to cell-surface PrP expression and it can
be applied to high throughput screening assays for therapeutic
approaches against prion diseases.
To conclude, confocal ﬂuorescence imaging was carried out on
neuroblastoma cells expressing fusions between the prion protein and
ﬂuorescent proteins GPI-anchored to the cell membrane to mimic the
endogenous location of the prion protein. Live-cell FRET measurements
indicate that increased interactions between neighbor prion protein
molecules are the initial event of prion interaction with cells and may
represent the initial step of prion replication and infectivity.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2014.02.002.
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